Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis Genovese, M. C., Fleischmann, R. M., Jasson, M., Radin, A. R., Hamilton, J., Huizinga, T. J. WILEY-BLACKWELL. 2012: S568

View details for Web of Science ID 000309748303041